Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.
Source: insidermonkey.com
Stay updated with breaking news from Sumant Kulkarni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.
CMPS earnings call for the period ending December 31, 2023.
CMPS earnings call for the period ending December 31, 2023.
Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic financing, and review...
Operator: Good afternoon. My name is Latif and I will be your conference facilitator.